« previous next »
Pages: [1]

Author Topic: (Abst.) Age and the risks of high-efficacy DMDs in MS  (Read 79 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9841
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) Age and the risks of high-efficacy DMDs in MS
« on: April 17, 2019, 02:42:04 pm »
From PubMed (April 16, 2019), "Age and the risks of high-efficacy disease-modifying drugs in multiple sclerosis":


https://www.ncbi.nlm.nih.gov/pubmed/30985373
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
2 Replies
100 Views 		Last post April 10, 2017, 09:08:52 pm
by agate
0 Replies
101 Views 		Last post May 11, 2019, 02:32:11 pm
by agate
1 Replies
91 Views 		Last post May 29, 2020, 09:45:07 pm
by agate
0 Replies
31 Views 		Last post March 22, 2020, 02:55:01 pm
by agate
1 Replies
7 Views 		Last post March 27, 2024, 02:58:23 pm
by agate